A patient treated with azithromycin and macrodantin for a urinary tract infection still has hematuria; urinalysis shows ketones, blood 3+, protein 2+, nitrites positive, leukocytes negative, and pending urine culture and sensitivity. What should be the next management steps?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 9, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Immediate Management: Investigate for Non-Infectious Causes of Persistent Hematuria

The patient requires immediate investigation for non-infectious causes of hematuria, as azithromycin is not an appropriate antibiotic for UTI and the persistent 3+ blood with negative nitrites/leukocytes suggests this may not be a simple UTI. While awaiting urine culture results, you should obtain renal imaging and consider urological referral.

Critical Assessment of Current Situation

The treatment regimen is fundamentally flawed. Azithromycin has no role in UTI treatment 1. The FDA label explicitly states azithromycin is not indicated for urinary tract infections—it lacks adequate urinary concentration and tissue distribution for treating uropathogens. Nitrofurantoin (Macrodantin) is appropriate for uncomplicated cystitis 2, but the FDA label warns that "many patients treated with Macrodantin are predisposed to persistence or reappearance of bacteriuria" and specifically states it is not indicated for pyelonephritis or perinephric abscesses 2.

Interpreting the Urinalysis Findings

Your urinalysis pattern is concerning:

  • Blood 3+ with negative leukocytes and negative nitrites suggests this may not be infectious hematuria
  • Protein 2+ alongside significant hematuria raises concern for glomerular pathology or upper tract disease
  • Ketones alone are nonspecific (fasting, dehydration, metabolic state)

False-positive dipstick hematuria can occur with bacteriuria due to bacterial hydroperoxidase activity 3, but this typically occurs with polymicrobic infections and your negative leukocytes make active infection less likely.

Immediate Next Steps (While Awaiting Culture)

1. Obtain Upper Tract Imaging Immediately

The 2024 EAU guidelines mandate evaluation of the upper urinary tract via ultrasound to rule out urinary tract obstruction or renal stone disease, particularly with renal function disturbances or high urine pH 4. Given the persistent hematuria despite treatment and significant proteinuria, you need:

  • Renal ultrasound as first-line imaging
  • Consider CT urogram if ultrasound is nondiagnostic, especially if patient has risk factors for malignancy or nephrolithiasis
  • The combination of hematuria + proteinuria warrants evaluation for glomerular disease

2. Check Renal Function and Consider Nephrology Consultation

The protein 2+ finding alongside persistent hematuria suggests possible:

  • Glomerulonephritis
  • IgA nephropathy
  • Other renal parenchymal disease

Obtain: serum creatinine, BUN, and consider spot urine protein-to-creatinine ratio.

3. Await Culture Results Before Further Antibiotics

The 2024 EAU guidelines state that for patients whose symptoms do not resolve, "a urine culture and antimicrobial susceptibility testing should be performed. For therapy in this situation, it should be assumed that the infecting organism is not susceptible to the agent originally used" 4.

Do not add empiric antibiotics until culture results return, unless the patient develops systemic symptoms (fever, flank pain, sepsis).

When Culture Results Return

If Culture is Positive:

  • Treat based on sensitivities with a 7-day course of an appropriate agent 4
  • First-line options for uncomplicated cystitis include: fosfomycin 3g single dose, nitrofurantoin 100mg BID for 5 days, or pivmecillinam 400mg TID for 3-5 days 4
  • If upper tract involvement suspected (given proteinuria): use fluoroquinolones (ciprofloxacin 500-750mg BID for 7 days or levofloxacin 750mg daily for 5 days) or cephalosporins 4
  • Nitrofurantoin should be avoided if pyelonephritis is suspected 4, 2

If Culture is Negative or Shows <50,000 CFU:

This strongly suggests non-infectious hematuria. Persistent hematuria after excluding UTI requires urological evaluation 5.

Timeline for Hematuria Resolution

Do not recheck urinalysis for at least 12 weeks 6. Recent data shows that only 38% of patients have resolution at 30 days and 50% at 60 days following UTI treatment. Retesting at 12 weeks optimizes the likelihood of true resolution (79% negative rate) and avoids false-positive rechecks 6. Earlier rechecking increases the likelihood of finding persistent microscopic hematuria that would have resolved spontaneously.

Urological Referral Indications

Refer to urology if:

  • Imaging reveals masses, stones, or structural abnormalities
  • Hematuria persists at 12-week recheck
  • Patient has risk factors for genitourinary malignancy (age >40, smoking history, occupational exposures, prior pelvic radiation)
  • Macroscopic hematuria develops 5

Cystoscopy will be needed to exclude bladder pathology if hematuria persists without clear infectious or nephrological cause.

Common Pitfalls to Avoid

  • Do not continue azithromycin—it has no efficacy for UTI
  • Do not assume this is treatment failure of appropriate antibiotics—the initial regimen was inappropriate
  • Do not recheck UA in 1-2 weeks—this leads to unnecessary further workup for physiologic delayed resolution
  • Do not ignore the proteinuria—this finding alongside hematuria suggests upper tract or glomerular involvement
  • Do not use nitrofurantoin if pyelonephritis is suspected—it achieves inadequate tissue levels 4, 2

Related Questions

What oral antibiotic should be used for a urinary tract infection now that the urine culture is positive for Staphylococcus (likely Staphylococcus saprophyticus) and nitrofurantoin should be stopped?
What is the appropriate management for a urinary tract infection exacerbation in a patient on chronic nitrofurantoin (Macrodantin) who has not improved after four days of therapy?
What antibiotic is appropriate for treating a urinary tract infection in a patient taking amiodarone who is allergic to nitrofurantoin (Macrobid) and sulfonamides?
What is the recommended nitrofurantoin dosing for uncomplicated urinary tract infection in adults, including adjustments for renal function, pregnancy, and in children?
In an 80‑year‑old woman with urinary urgency, nitrite‑positive and hematuria on urinalysis, a sulfa allergy, and a recent course of nitrofurantoin (Macrobid) three months ago, what is the recommended first‑line therapy for her presumed uncomplicated urinary tract infection?
Can a spinal interbody cage improve sensation and mobility in my back?
Can doxepin prolong the QT interval, especially at doses above 25 mg, and what monitoring and precautions are recommended for at‑risk patients?
For a patient undergoing cannabis withdrawal, what is the expected duration of increased REM sleep and vivid dreaming?
What should I tell a patient who is experiencing blackouts while taking clonazepam (Klonopin) 0.5 mg nightly, deutetrabenazine (Austedo XR) 24 mg nightly, paliperidone (Invega) 3 mg daily, suvorexant (Belsomra) 20 mg nightly, trazodone 150 mg 2–3 tablets nightly, and trihexyphenidyl 5 mg, and who is requesting an early outpatient psychiatry appointment?
As a neurosurgery resident, what are the considerations for selecting and managing batteries in deep brain stimulation (DBS) systems?
What is the likely cause of left lumbar (lower back) pain with mild numbness when sitting?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.